These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18648367)

  • 1. Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy.
    Jung K
    Br J Cancer; 2008 Aug; 99(3):553-4; author reply 555. PubMed ID: 18648367
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum matrix metalloproteinase-9 level as a biomarker for colorectal cancer: a diagnostic meta-analysis.
    Liang S; Chang L
    Biomark Med; 2018 Apr; 12(4):393-402. PubMed ID: 29575908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum matrix metalloproteinase 9 concentration predicts the presence of colorectal neoplasia in symptomatic patients.
    Belobrajdic DP; Cosgrove LJ; Phatak A
    Br J Cancer; 2008 May; 98(9):1593; author reply 1594. PubMed ID: 18414416
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating Levels of Matrix Metalloproteinase-9 in Patients with Colorectal Cancer.
    Sonnante AM; Correale M; Linsalata M; Di Leo A; Guerra V
    Scand J Gastroenterol; 2000 Jun; 35(6):671-2. PubMed ID: 10912671
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.
    Otero-Estévez O; De Chiara L; Rodríguez-Girondo M; Rodríguez-Berrocal FJ; Cubiella J; Castro I; Hernández V; Martínez-Zorzano VS
    Sci Rep; 2015 Aug; 5():13030. PubMed ID: 26264519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
    Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
    Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer.
    Damery S; Nichols L; Holder R; Ward ST; Warmington S; Wilson S; Wakelam MJ; James J; Ismail T
    Br J Cancer; 2013 Mar; 108(5):1149-56. PubMed ID: 23392084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers.
    Emara M; Cheung PY; Grabowski K; Sawicki G; Wozniak M
    Clin Chem Lab Med; 2009; 47(8):993-1000. PubMed ID: 19569980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.
    Hurst NG; Stocken DD; Wilson S; Keh C; Wakelam MJ; Ismail T
    Br J Cancer; 2007 Oct; 97(7):971-7. PubMed ID: 17912241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.
    Wilson S; Taskila T; Ismail T; Stocken DD; Martin A; Redman V; Wakelam M; Perry I; Hobbs R
    BMC Cancer; 2009 Jan; 9():36. PubMed ID: 19175925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer.
    Rašić I; Rašić A; Akšamija G; Radović S; Šehović N
    Med Glas (Zenica); 2017 Aug; 14(2):229-235. PubMed ID: 28644426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of novel combinations of biomarkers for the detection of colorectal cancer.
    Shimwell NJ; Wei W; Wilson S; Wakelam MJ; Ismail T; Iqbal T; Johnson PJ; Martin A; Ward DG
    Cancer Biomark; 2010; 7(3):123-32. PubMed ID: 21263188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster].
    Frenoux C; Rebischung C; Quesada JL; Mendosa C; Letoublon C; Trocmé C
    Bull Cancer; 2018 Oct; 105(10):884-895. PubMed ID: 30243479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis.
    Meng C; Yin X; Liu J; Tang K; Tang H; Liao J
    PLoS One; 2018; 13(11):e0207039. PubMed ID: 30458003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
    Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
    Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures.
    Lech Pedersen N; Mertz Petersen M; Ladd JJ; Lampe PD; Bresalier RS; Davis GJ; Demuth C; Jensen SØ; Andersen CL; Ferm L; Christensen IJ; Nielsen HJ
    Clin Chim Acta; 2020 Aug; 507():39-53. PubMed ID: 32272156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-derived molecular signatures as biomarker panels for the early detection of colorectal cancer.
    Gan X; Wang T; Chen ZY; Zhang KH
    Mol Biol Rep; 2020 Oct; 47(10):8159-8168. PubMed ID: 32979165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of tumor-associated proteases in colorectal cancer.
    Kushlinskii NE; Gershtein ES; Korotkova EA; Prorokov VV
    Bull Exp Biol Med; 2013 Jan; 154(3):365-9. PubMed ID: 23484202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.